Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty acid translocase (CD36) is a membrane protein that functions as a long-chain fatty acid transporter. It is present at the plasma membrane and in intracellular pools, including mitochondria of skeletal muscle. In mitochondria, CD36 facilitates the uptake of long-chain fatty acids for β‑oxidation—a critical process for energy production in tissues such as heart and muscle. Functional studies show that inhibition of CD36 significantly reduces mitochondrial palmitate oxidation, indicating its essential role in mitochondrial fatty acid import. The content of mitochondrial CD36 correlates with tissue capacity for fatty acid oxidation and can be dynamically regulated by physiological stimuli such as chronic or acute muscle stimulation[5]. Defects or deficiencies in proteins involved in mitochondrial fatty acid transport—including but not limited to CD36—are associated with metabolic diseases like hypoketotic hypoglycemia, cardiomyopathy, arrhythmia, and rhabdomyolysis[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty acid translocase (CD36) (CD36).